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ABSTRACT
Reliability and Validity Practices in Randomized Controlled Trials:
Current Trends and Recommendations
Jennifer A. Z. Romano
Department of Psychology, BYU
Master of Science
The verity of conclusions drawn from psychological research hinges on the reliability and
validity of the measures used to collect the data. Any research conducted using measures with
low reliability or validity is rendered essentially useless; thus, reporting reliability and validity
evidence for measures employed in research is an essential component in creating rigorous,
replicable research. Multiple reporting standards have been implemented and revised over the
years with the intent to improve measurement and reporting practices within clinical psychology,
though few guidelines have been suggested regarding adequate reporting practices for studies’
measures. We reviewed a representative sample of randomized clinical trials (RCTs) published
in the Journal of Clinical and Counseling Psychology in 1994, 2002, 2010, and 2018 for reported
reliability and validity evidence. We examined whether the implementation of reporting
standards led to improvement in reporting measures’ reliability and validity evidence over time,
along with how frequently articles recently published in one of the top clinical psychology
journals reported reliability and validity evidence. We found that only 58.1% of measures used in
articles published in 2018 reported reliability evidence, and only 12.4% reported validity
evidence. Furthermore, although reporting of reliability and validity evidence has improved
when comparing articles published in 2018 to those published in 1994 or 2002, such reporting
practices were not significantly different from articles published in 2010. We provide a
discussion of the importance of these findings and recommendations for improving reporting
practices in future research.
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Reliability and Validity Practices in Randomized Controlled Trials:
Current Trends and Recommendations
Psychology is in the midst of a replication crisis (Lilienfeld, 2017; Pashler &
Wagenmakers, 2012; Shrout & Rodgers, 2018; Spellman, 2015). Psychological scientists and
practitioners alike rely on published studies to guide best treatment practices and to identify
evidence-based treatments; when study results do not replicate, their findings are thrown into
question. A reproducibility study of 100 studies demonstrated that the current body of
psychological research has low replicability: only 36% of replications had significant results,
while 97% of the original studies had significant findings. In addition, the 95% confidence
interval of the replication effect size only contained 47% of the originally reported effect sizes
(Open Science Collaboration, 2015), indicating that reported effect sizes replicated in fewer than
half of the studies. Though the replication crisis began with the frequent failure to replicate
studies published in social and cognitive psychology, subsequent studies also show replication
failures in clinical psychology (Munafò et al., 2017; Tackett et al., 2017).
The replication crisis has led to individuals proposing many different solutions. In an
effort to improve the reproducibility of findings and the transparent reporting of study designs,
many have begun to call for researchers to preregister their studies (Munafò et al., 2017; Nosek
et al., 2018), an often time-consuming process with few researcher incentives (Murray et al.,
2019). The preregistration of studies is being adopted at an accelerated rate in psychology
(Nosek & Lindsay, 2018). Even with incentives changing to reward preregistration (Nosek &
Lindsay, 2018), many studies are still being published without preregistration. For example,
Murray et al. (2019) found that despite increased preregistration incentives and the risk of being
fined for failing to report transparent summary data, less than 10% of anorexia nervosa treatment

RELIABILITY AND VALIDITY REPORTING IN JCCP

2

articles published in peer-reviewed journals demonstrated evidence of preregistration. Others
have advocated for increased training in statistics, measurement, and methodology; Aiken, West,
and Millsap (2008) indicated that most Ph.D. programs included in their study only required their
students to take one introductory level statistics course. With such little training in statistics and
measurement, the lack of reproducibility in clinical psychology research may be contributed to,
at least in part, by researchers not fully attending to measurement.
Measurement in psychology and other social sciences has many challenges. In
psychology, researchers often study constructs which cannot be directly measured. They must
first create an operational definition of the construct, which may not capture every facet of the
construct; or, if it successfully captures every facet, it may require such a heterogeneous and
complex measure that the time it would take to employ the measure may outweigh its theoretical
utility. In addition, many psychological constructs are related, even overlapping with one
another, and creating meaningful distinctions between them is difficult (Naragon-Gainey et al.,
2018). Different measurement methods, such as the frequently employed self-report method, also
have limitations that may prevent researchers from fully understanding the construct of interest
(Wood et al., 2001). For example, self-report measures rely on an individual’s level of insight
and may often be influenced by response biases and social desirability (Nisbett & Wilson, 1977).
In addition, validity evidence for a measure is difficult to find and is often generated by
comparing a new measure with an older measure of the same construct, rather than an external
factor that could validate the measure (Clark & Watson, 2019).
Poor measurement practices, including the failure to report and replicate validity and
reliability evidence, can influence research in various ways. Estimates of reliability and validity
are dependent on the population and context being studied (Clayson & Miller, 2017; Smith &
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McCarthy, 1995); therefore, an estimate obtained from one population or context may not
replicate in another population or context. Clayson & Miller (2017) give the example that the
reliability and validity scores of a measure of depressive symptoms in an undergraduate sample
may not generalize to other populations such as a geriatric population or other contexts such as
an outpatient clinic. Even in similar samples (e.g., an undergraduate population in two different
universities), other contextual factors may differ between the samples in such a way that the
reliability and validity estimates obtained in one sample fail to generalize across samples. If the
scores from a measure have poor validity, our conclusions from the research we conduct may be
erroneous, as we may not be measuring what we purport to measure. We may never know this if
we do not repeatedly calculate and report the validity of the measure each time it is used. If a
scores from a measure demonstrate high reliability in one sample but poor reliability in other
samples, studies using this measure will not have consistent results. Loken and Gelman (2017)
addressed the common misconception that measurement error always reduces effect sizes,
demonstrating that studies with small sample sizes (especially those with fewer than 500
participants) frequently have inflated effect sizes due to measurement error. Such measurement
error often arises when measures have low reliability; thus, the lack of reporting reliability
evidence may result in false-positive results that fail to replicate in future studies.
Just as researchers have many possible decisions to make that may lead them to analyze
data differently while attempting to answer the same research question, as illustrated in a study
conducted by Silberzahn et al. (2018), researchers also have many possible decisions to make
regarding measurement. For example, many of the measures utilized in depression research use
a design in which symptoms are summed to generate a depression score. However, Fried and
Nesse (2015) identified 1030 unique symptom profiles of outpatients with depression. With such
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heterogeneity in the symptom presentation of depression, simply generating sum-scores and
classifying depressed individuals as those who meet a certain threshold may not represent the full
construct of depression, thus threatening the construct validity of the depression measure. Such a
measure may produce false-negative findings in studies, simply because it fails to capture the
true heterogeneity of depression presentation. In a similar manner, measures normed on a sample
with a homogenous symptom presentation of depression will fail to have acceptable construct
validity by failing to capture the true heterogeneity of depression presentation, and its findings
may not replicate across samples of individuals with a depression symptom presentation that is
different from the original sample.
Flake and Fried (2019) identified many questionable measurement practices (QMPs) that
might threaten the validity of a study’s conclusions. They explained that QMPs prevent
researchers from being able to identify such threats. Common QMPs include the creation of
measures that have never been used before, the failure to report reliability and validity evidence
for the measures employed, and the omission of analyzed scales from published research. They
provide specific questions designed to promote transparency and improve the rigor of
measurement practices, including questions about why measures were selected, why and how
measures were modified, and whether the measure was created “on the fly” (p. 9) along with
justification for creating the new measure.
Similar to Flake and Fried's (2019) emphasis on avoiding QMPs, one of the most
common responses to the replication crisis has been an increased emphasis on transparent
reporting practices. Lack of transparency at any stage of a study, including study design, data
collection, measurement, and analysis, often culminates in researchers engaging in questionable
research practices (John et al., 2012; Simmons et al., 2011) or, in more extreme cases, p-hacking
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(Vazire, 2017). In a survey that incentivized truth-telling, John et al. (2012) reported that 94% of
researchers admitted having committed at least one QRP. Regardless of whether the practice is
judged to be justifiable by the researcher, transparent reporting of such practices is key. Failing
to disclose these practices in the past threatens to erode trust in science, as consumers of
scientific research find themselves unable to distinguish between psychologically rigorous
research and its more questionable counterpart (Vazire, 2017).
Efforts to improve the transparency of clinical trials have been ongoing since the 1990s.
Psychologists have implemented guidelines such as the Consolidated Standards of Reporting
Trials (CONSORT; Schulz, Altman, & Moher, 2010) and the Journal Article Reporting
Standards (JARS; Appelbaum et al., 2018) to help increase the rigor of clinical trials and
improve the reporting of psychological research generally. The most updated CONSORT
Statement (Schulz et al., 2010) was designed as a guideline for reporting practices of randomized
clinical trials (RCTs). It includes a 25-item checklist of information (p. 699) for researchers to
include throughout the entire article. Some items simply require explicit statements, such as
identifying the article as an RCT in the title (Item 1a) or explicitly stating any changes to the
primary and secondary outcomes in a trial after the commencement of the trial, along with the
reasons for the changes (Item 6b). Other items require more detail, such as the exploration of the
study’s limitations and sources of potential bias, imprecision, and, if relevant, the multiplicity of
analyses in the paper’s discussion (Item 20). Of note, Item 6a, which requires that primary and
secondary outcome measures are “completely defined” and pre-specified, is the only item
directly relating to reporting practices for measures.
The most recent version of JARS (Appelbaum et al., 2018) was published in 2018 and,
similar to the 2010 CONSORT Statement (Schulz et al., 2010), includes information
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recommended for inclusion in quantitative research manuscripts, from the abstract through the
discussion section. In addition to requiring researchers to clearly report designated primary and
secondary measures, regardless of whether they were included in the report, it requires authors to
report any steps they took to “enhance the quality of measurements” (p. 2), including reporting
interrater reliability. No other guidelines are given for the reporting of the psychometric evidence
for the measures included in the study. These reporting guidelines are important, as they help
psychologists communicate in a standardized way about their procedures; however, the standards
provide little guidance about reporting practices for measurement.
Though the explicit reporting of reliability and validity evidence for measures has not yet
been included in CONSORT (Schulz et al., 2010) or JARS (Appelbaum et al., 2018), reliability
and validity evidence are key components to rigorous study design and transparent reporting
practices. The conclusions in psychological research are only as good as the measures used in the
research, and psychologists may simply be using some measures because the measures are
considered the standard in the field. For example, the Beck Depression Inventory, Second edition
(BDI-II), is a popular measure for depression, with 10 of 14 studies identifying it as a tool used
to a high degree in training and practice, a valuable clinical tool, and an instrument of choice in
the assessment of mood disorders (Piotrowski, 2018). It is often assumed that these commonly
used measures, such as the BDI-II, are only used so frequently due to the preponderance of
psychometric evidence in their favor, though such evidence may not be commonly reported.
Though such measures might have high reliability and validity, as is commonly assumed,
without reporting the reliability or validity evidence of these measures, readers are expected to
posit faith in the wisdom of the researchers’ selection of measures. If, however, this assumption
is false, the practice of using such “gold standard” measures with weak psychometric evidence
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would almost certainly result in problematic research that is not replicable or reflective of the
real effects the researchers are attempting to study, essentially rendering such research useless.
To our knowledge, there has not been any systematic review of measurement reporting
practices in psychotherapy clinical trials. As the first step in evaluating and improving
measurement reporting is raising awareness of current measurement reporting practices, the
primary purpose of this study is to review and evaluate the frequency with which researchers
report and replicate reliability and validity evidence of the measures used. We will focus on
psychotherapy research utilizing RCTs. Specifically, we will review what researchers report with
respect to reliability and validity evidence of the measures used in RCTs published in the
Journal of Consulting and Clinical Psychology (JCCP) in four different years. The JCCP is
considered a leading journal in clinical psychology, with an impact factor of 4.54. It has
regularly required studies published within it to comply with current reporting guidelines and
currently requires RCTs to comply with the JARS (Appelbaum et al., 2018) reporting guidelines,
so we expect the reliability and validity reporting practices of the research published in JCCP to
be a valid representation of such reporting practices within the field of psychology. In addition, if
reporting practices in early years are not exemplary, we expect that the implementation of
reporting guidelines will improve the reporting and methodological rigor of studies published
more recently as compared to earlier years; thus, our study will also focus on comparing the
frequency with which reliability and validity evidence was reported in JCCP RCTs in 2018 as
compared to 1994, 2002, and 2010. The first widely implemented reporting standard
(CONSORT; Schulz et al., 2010) was published in 1996; our chosen years will sample RCTs
prior to the first publication of CONSORT (Schulz et al., 2010), along with sampling RCTs six
to nine years after its 1996 publication and each of its subsequent revisions in 2001 and 2010. A
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secondary aim of this study is to offer recommendations for improving the reporting practices
within psychology so as to strengthen research findings and their replicability within psychology.
Method
Sampling and Procedures
We sampled randomized trials from four years of the Journal of Consulting and Clinical
Psychology (JCCP): 1994, 2002, 2010, and 2018. After searching for all articles published in
JCCP during these four years, we selected up to 15 articles from each year. For years with more
than 15 RCT articles in a given year (2002, 2010, and 2018), we randomly sampled 15. Any
JCCP articles in the given year without an RCT design were excluded from the study.
Our study methods and analyses are preregistered on the Open Science Framework
(OSF), a free website designed to make the research process more transparent and reproducible.
All data are stored on OSF and accessible to the public. The primary researchers have access to
edit the data, and a full history of edits to the data and the analyses are publicly displayed on
OSF. The link to our study is
https://osf.io/rbz9t/?view_only=f9783f3340b64bc3afe021d6ef6f14ac.
Coding of Articles
All studies were coded by two graduate students. When there were discrepancies, the
coders met and resolved discrepancies. Any discrepancies that could not be resolved between the
two coders were resolved during a discussion with the thesis supervisor (Scott Baldwin).
Following the procedures outlined in the coding manual (included in the appendix), we
created study-level codes and measure-level codes. Regarding study-level codes, we coded the
year of publication, the chronological location of the RCT study in our sample from that year
(e.g., 3 = the third study in that year), and the study’s sample size, as recorded in the “Methods”
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section. Next, we coded whether the study reported one or more primary outcomes (1 = yes, 0 =
no), the number of primary outcomes identified, whether the study identified one or more
primary measures (1 = yes, 0 = no), and the number of primary measures identified. Primary
outcomes are designated by the researcher as the most important outcome(s) (e.g., blood alcohol
level, IQ score) among all outcomes examined, while primary measures are considered to be the
most important measure(s) of one or more primary outcomes. In addition, we coded the total
number of measures reported in the “Measures section” and the total number of measures
reported in the study’s tables. As the primary outcomes are typically stated in the last page of the
“Introduction” section and the information on measures is typically explicated in the “Measures”
section, we limited our search for this information to these sections of the sampled studies.
For each measure in the studies sampled, we coded for reliability and validity evidence as
it is reported in the “Measures” section (or the equivalent section in the “Methods” section if no
“Measures” section could be found). We focused on the “Measures” section because that is
where the psychometric properties of the study’s measures are typically reported. We created
codes for the year, the chronological location of the study in our sample from that year as
explained above, and the chronological location of the measure within the study (e.g., 2 = the
second measure listed). We coded for whether subscales of a measure are treated as independent
measures (1 = yes, 0 = no), and whenever this occurred, we treated each subscale as its own
measure, coding for reliability and validity evidence for each subscale. In addition, we coded for
whether the measure consisted of a selection of items from a larger measure or subscale (1 = yes,
0 = no). We also coded whether the measure was identified as a primary measure (1 = yes, 0 =
no) and whether the measure was created or altered by the authors primarily for use in the given
study (0 = not created or altered, 1 = created by author(s), 2 = altered by author(s), 3 =
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unknown/unclear). In addition, we recorded the construct being measured and the method (e.g.,
self-report, formal assessment, physical/biological measure) employed by the measure.
Because we expected that the most common reliability statistic reported would be
Cronbach’s alpha, we coded for the presence of alpha calculated from the given study’s data (1 =
yes, 0 = no), the presence of another reliability statistic calculated in the given study (1 = yes, 0 =
no), the presence of citations reporting one or more reliability statistics from previous data (1 =
yes, 0 = no), the presence of qualitative reporting of reliability evidence (1 = yes, 0 = no), and the
number of studies cited to support reliability evidence. We repeated this coding procedure for the
internal consistency, test-retest, and interrater reliability evidence for every reported measure in
the sampled studies.
Similarly, we coded for the presence of a validity statistic calculated from the given
study’s data (1 = yes, 0 = no), the presence of citations reporting one or more validity statistics
from previous data (1 = yes, 0 = no), the presence of qualitative reporting of validity evidence (1
= yes, 0 = no), and the number of studies cited to support validity evidence. We repeated this
coding procedure for the construct, factorial, convergent, discriminant, and predictive validity
evidence for every reported measure in the sampled studies.
During the coding process, we encountered a study that only employed a subscale of a
measure, yet reported psychometric evidence for the entire measure and not for the subscale. In
anticipation of encountering more studies that employed this practice, we added a third option to
all reliability and validity evidence codes (2 = evidence for the entire measure, but not
specifically for the subscale/portion researchers are using).
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Interrater reliability
To assess the interrater reliability of the coding procedure described above, two graduate
students independently coded ten JCCP RCT studies from 2017. For categorical variables,
percentage agreement ranged from 80% to 100%, with a median of 100%; kappa ranged from
0.62 to 1.00, with a median of 1.00; and for continuous variables, the correlation between raters
ranged from r = 0.75 to 1.00, with a median of 1.00. All variables were sufficiently reliable to
proceed with the analysis.
Data Analysis
We used R (R Core Team, 2016) to randomly sample 15 articles from each year in which
more than 15 RCTs meeting our inclusion criteria were present; these were 2002, 2010, and
2018. 1994 had exactly 15 RCTs meeting our inclusion criteria. After randomly selecting articles
from all four years, we encountered 12 articles in 2010 and one article in 2002 that either did not
meet sampling criteria (and thus were excluded from analysis) or stated in the “Methods” section
that more information about participants and/or measures were recorded in an earlier study.
Consequently, these articles were excluded from analysis, as they would not be expected to
report the same detail of information on measures and participants as articles reporting on this
data for the first time. The random sampling process was repeated for all articles not yet coded
from that year until 15 articles meeting all inclusion criteria had been selected. All statistical
analyses were run in Stata 15 (StataCorp, 2017). The following PRISMA flow diagrams
demonstrate our sampling procedures.
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Included

Eligibility

Screening

Identification

PRISMA 2009 Flow Diagram: 1994 Sample

Records identified through
searching PsycINFO
(n = 19)

Records after duplicates
removed
(n = 19)

Records screened
(n = 19)

Records excluded
(n = 4)

Full-text articles assessed
for eligibility
(n = 15)

Full-text articles excluded
(n = 0)

Studiesrandomized
included infor
Studies
qualitative
synthesis
analysis
(n = 15)

Studies included in
qualitative synthesis
(n = 15)

Figure 1. PRISMA 2009 flow diagram: 1994 sample.
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Included

Eligibility

Screening

Identification

PRISMA 2009 Flow Diagram: 2002 Sample

Records identified through
searching PsycINFO
(n = 20)

Records after duplicates
removed
(n = 20)

Records screened
(n = 20)

Records excluded
(n = 3)

Full-text articles assessed
for eligibility
(n = 17)

Full-text articles excluded:
not an RCT design
(n = 1)

Studies randomized for
analysis
(n = 16)

Studies included in
qualitative synthesis
(n = 15)

Figure 2. PRISMA 2009 flow diagram: 2002 sample.
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Included

Eligibility

Screening

Identification

PRISMA 2009 Flow Diagram: 2010 Sample

Records identified through
searching PsycINFO
(n = 40)

Records after duplicates
removed
(n = 40)

Records screened
(n = 40)

Records excluded
(n = 7)

Full-text articles assessed
for eligibility
(n = 33)

Full-text articles excluded:
not an RCT design
(n = 12)

Studies
randomized
Studies
included infor
analysis
qualitative
synthesis
21)
(n = 15)

Studies included in
qualitative synthesis
(n = 15)

Figure 3. PRISMA 2009 flow diagram: 2010 sample.
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Included

Eligibility

Screening

Identification

PRISMA 2009 Flow Diagram: 2018 Sample

Records identified through
searching PsycINFO
(n = 38)

Records after duplicates
removed
(n = 38)

Records screened
(n = 38)

Records excluded
(n = 8)

Full-text articles assessed
for eligibility
(n = 30)

Full-text articles excluded
(n = 0)

Studies
Studiesrandomized
included infor
analysis
qualitative
synthesis
30)
(n = 15)

Studies included in
qualitative synthesis
(n = 15)

Figure 4. PRISMA 2009 flow diagram: 2018 sample.
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Results
Description of Studies and Measures
On average, we coded 7.5 (standard deviation [SD] = 4.4) measures per article, with a
total of 450 measures across all studies. Self-report measures were the most common type of
measure used, with 37.6% (169) of measures designated by the authors as self-report measures;
31.3% (141) of the measures did not report enough information to deduce the measure type. Of
the 450 measures, 2.0% (9) were created by the study authors for use in the study, and 4.9% (22)
were altered by the study authors. 12.4% (56) of the measures appeared to have been created or
altered, but it was unclear whether they had been altered by study authors for use in the coded
study or if they had been used in their altered forms in other studies. Table 1 displays the percent
of studies identifying primary outcomes and primary measures for each year of articles sampled.
Primary outcomes are the researcher-designated most important outcome(s) (e.g., blood alcohol
level, IQ score) among all outcomes examined, while primary measures are considered to be the
most important measure(s) of one or more primary outcomes.
Table 1
Percent Primary Outcomes and Measures Identified by Year Published
Year
Number of
Mean Number of
Primary Outcomes
Studies
Measures per Study
Identified
1994
15
9.6
0.0
2002
15
7.7
6.7
2010
15
5.7
26.7
2018
15
7.0
66.7

Primary Measures
Identified
6.7
6.7
33.3
60.0
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Reliability and Validity Evidence Reported
Table 2 shows the percent of measures where a study reported any kind of reliability
evidence and the percent of measures where a study reported any kind of validity evidence for
each year of articles sampled. This includes reliability and validity evidence cited from previous
studies (including those not reporting a statistic), along with evidence calculated from the given
study’s data (current reliability/validity evidence). Internal consistency reliability was the most
frequent type of reliability evidence reported, with internal consistency reliability evidence
reported on 25.6% (115) of all measures and 52.4% (55) of 2018 measures. Convergent validity
was the most frequent type of validity evidence reported, with convergent validity evidence
reported on 4.0% (18) of all measures and 6.7% (7) of 2018 measures.

Table 2
Percent Measures Reporting Reliability and Validity Evidence by Year Published
Year
Number of Measures
Reliability Evidence
Validity Evidence
1994
144
18.1
3.5
2002
116
23.3
4.3
2010
85
47.1
14.1
2018
105
58.1
12.4
Table 3 shows the percent of measures reporting current reliability evidence, and the
percent of measures reporting current validity evidence was calculated from the given study’s
data each year. Internal consistency reliability was the most common type of current reliability
evidence reported, with 20.7% (93) of all measures and 48.6% (51) of 2018 measures reporting
internal consistency reliability calculated from the given study. Therefore, almost half of all
measures reporting current internal consistency reliability evidence were from 2018 studies.
Convergent validity was the most common type of current validity evidence, with 0.9% (4) of all
measures and 2.9% (3) of 2018 measures reporting convergent validity calculated from the given

RELIABILITY AND VALIDITY REPORTING IN JCCP

18

study. Therefore, all but one of the measures reporting convergent validity evidence were from
2018 studies. Of the 154 measures for which reliability evidence was reported, 15.6% (24) used a
descriptive term with no accompanying statistic to report some form of reliability evidence. Of
the 35 measures for which validity evidence was reported, 71.4% (25) used a descriptive term
with no accompanying statistic to report some form of validity evidence.
Table 3
Percent Measures Calculating Reliability and Validity Evidence by Year Published
Year
Number of Measures
Reliability Evidence
Validity Evidence
1994
144
11.8
0.0
2002
116
19.8
0.0
2010
85
30.6
1.2
2018
105
51.4
2.9
Regression Analysis
Reliability Evidence
Table 4 displays the unstandardized regression coefficients for the percent of measures
reporting reliability evidence by year published. Articles published in 2018 reported significantly
more reliability evidence for their measures than articles published in 1994 (b = - 0.40 p < 0.001;
95% Confidence Interval [CI] = [- 0.51, - 0.29]) or 2002 (b = - 0.35, p < 0.001; 95% CI = [- 0.47,
- 0.23]). For example, an article published in 1994 reported reliability evidence for 40% fewer of
its measures, on average, than the average article published in 2018. Articles published in 2010
did not differ significantly from those published in 2018 with respect to the percent of measures
for which reliability evidence was reported (b = - 0.11, p < 0.09; 95% CI = [- 0.24, 0.02]).
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Table 4
Regression Analysis Predicting Percent Reliability Evidence by Year Published
Variable
B
SE b
p
95% Confidence Interval
Lower
Upper
Constant
0.58
0.04
< 0.001
0.50
0.67
1994
- 0.40
0.06
< 0.001
- 0.51
- 0.29
2002
- 0.35
0.06
< 0.001
- 0.47
- 0.23
2010
- 0.11
0.07
0.09
- 0.24
0.02
Notes. R2=0.12
Validity Evidence
Table 5 displays the unstandardized regression coefficients for the percent of measures
reporting validity evidence by year published. Articles published in 2018 reported significantly
more validity evidence for their measures than articles published in 1994 (b = - 0.09, p = 0.01;
95% CI = [- 0.16, - 0.02]) or 2002 (b = - 0.08, p = 0.02; 95% CI = [- 0.15, - 0.01]). For example,
an article published in 1994 reported validity evidence for 9% fewer of its measures, on average,
than the average article published in 2018. Articles published in 2010 did not differ significantly
from those published in 2018 with respect to the percent of measures for which validity evidence
was reported (b = 0.02, p < 0.65; 95% CI = [- 0.06, 0.09]).
Table 5
Regression Analysis Predicting Percent Validity Evidence by Year Published
Variable
B
SE b
p
95% Confidence Interval
Lower
Upper
Constant
0.12
0.03
< 0.001
0.07
0.17
1994
- 0.09
0.03
0.01
- 0.16
- 0.02
2002
- 0.08
0.04
0.02
- 0.15
- 0.01
2010
0.02
0.04
0.65
- 0.06
0.09
Notes. R2=0.03

RELIABILITY AND VALIDITY REPORTING IN JCCP

20

Discussion
The primary purpose of this study is to review and evaluate the frequency with which
researchers report and replicate reliability and validity evidence of the measures used. A
secondary aim of this study is to offer recommendations for improving the reporting practices
within psychology so as to strengthen research findings and their replicability within psychology.
Reporting of Reliability Evidence
The vast majority of psychological research measures latent constructs. One challenge
with measuring a latent variable is measuring it with sufficient reliability. If a measure of a
construct is not sufficiently reliable, it is difficult, if not impossible, to detect true differences
between groups, as the error variability will overshadow the true variability. The best measures
are consistent in multiple ways, including demonstrating consistency within a given sample
(internal consistency reliability; ICR), across time (test-retest reliability), and across raters (if the
measure is coded; interrater reliability). ICR evidence was the most commonly reported
reliability evidence, yet it was only reported for 25.6% of the measures sampled. In 2018, ICR
evidence was reported for 52.4% of measures, suggesting that though psychological articles are
far from reporting ICR evidence for every measure, ICR evidence reporting practices have
improved over time, possibly due to the implementation of reporting standards such as
CONSORT and JARS.
In addition, the reliability statistic generated for a measure in one study may differ due to
changes in sample characteristics such as age, gender, or race. Because of this, calculating
reliability statistics of a measure in the current sample is a crucial step to determining whether
the measure produces reliable results in a given study. ICR evidence was the most common type
of current reliability evidence reported, and yet it was only reported for 20.7% of the measures in
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our sample. In 2018, current ICR evidence was reported for 48.6% of measures. Therefore,
though psychological articles are far from calculating ICR for every measure in every study,
current ICR evidence reporting practices have improved over time.
Although studies published in 2018 reported significantly more reliability evidence for
their measures than those published in 1994 or 2002, still only slightly more than half of the
measures from studies published in 2018 reported some form of reliability evidence. Thus,
almost half of all measures used in 2018 JCCP studies do not report reliability evidence of any
kind, despite JCCP requiring RCTs to follow the JARS (Appelbaum et al., 2018) guidelines.
These studies may have reported a general statement regarding the psychometric properties of
the measure; this practice will be discussed in further depth below. Without reporting reliability
evidence, it is difficult to know whether study results reflect true patterns in the data or patterns
generated by error variance.
Reporting of Validity Evidence
Another challenge in psychological research is creating valid measures. As with
reliability, the best measures demonstrate multiple forms of validity, including the extent to
which a measure captures the construct it is designed to measure (construct validity), to which a
measure’s items reflect latent factors (factorial validity), to which a measure generates results
consistent with another way to measure the construct (convergent validity), to which a measure
generates results that differ from measures of unrelated constructs (discriminant validity), and
the extent to which a measure is able to predict results related to the construct (predictive
validity). Although studies published in 2018 reported significantly more validity evidence for
their measures than those published in 1994 or 2002, still only about one of every eight measures
from studies published in 2018 reported some form of validity evidence, and less than 3% of
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2018 measures calculated a validity statistic from the current sample. Without reporting and
replicating validity evidence for our measures, researchers cannot draw conclusions about
whether the scores reflected in the study are a valid representation of the construct of interest. If
a measure is not valid, the conclusions drawn from the measure’s data are likely to be invalid as
well.
Researchers may not report validity evidence for a variety of reasons. For example, they
may rely on the measures traditionally used in their field of study, assuming the widespread use
of such measures is founded on evidence of its validity or a basis for validity evidence. Many
measures are face valid, and because they appear to be asking about the construct of interest,
researchers may consider such face validity as necessary and sufficient evidence that the measure
is accurately assessing what it was designed to measure. Similarly, researchers may hold the
misconception that reliability is necessary and sufficient evidence for validity (e.g., that people
who consistently report a high score on a measure of anxiety must be high in anxiety). In
addition, validity is more difficult to measure, as no widely accepted “validity statistic” exists;
therefore, it may be more difficult to measure and to locate instances of validity evidence in past
research. Perhaps the most important reason researchers may not report validity evidence is
because few editors and reviewers mandate researchers to demonstrate that the study’s measures
are valid for their use. Regardless of the underlying reason, researchers fail to report validity
evidence, the current dearth of studies reporting validity evidence for their measures indicates the
need for improvement.
Impact of Implementing Reporting Standards
Over time, psychological research practices regarding reporting reliability and validity
evidence has improved, though it did not change significantly between 2010 and 2018. Along
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with the replication crisis and subsequent focus on improving the rigor of psychological research,
the implementation of reporting standards such as CONSORT (Schulz et al., 2010) is likely
responsible for some of the improvement in psychometric reporting practices. It appears,
however, that the 2010 update of CONSORT (Schulz et al., 2010), along with the
implementation of the first publication of JARS (Appelbaum et al., 2018) in 2008, may not have
improved psychometric reporting of measures within psychological research, as 2018 did not
significantly differ from 2010 in the percent of measures reporting reliability and validity
evidence. Such reporting standards are vital to incentivizing better reporting practices. However,
a substantial percentage of measures do not have reliability and validity evidence reported in
studies published in a top psychology journal in 2018. We recommend some simple changes that
researchers can implement to increase the transparency surrounding psychometric reporting of
the measures they use.
Recommendations
First, researchers should be required to report more than ICR evidence for the measures
included in the study. Although ICR helps us understand whether a given sample demonstrated
consistent patterns of responding, it does not tell us anything about the measure’s reliability
across any other dimension (e.g., across time). In addition, reliability is necessary but not
sufficient for validity; i.e., a measure must be reliable to be valid, but reliability says nothing
about whether the measure is capturing the construct it was designed to measure. In addition to
reporting ICR, for any measures that have been used across multiple timepoints or that require
coding, we recommend reporting test-retest or interrater reliability, respectively, for those
measures.
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In addition, we recommend reporting validity evidence for all measures included in the
study. Ideally, researchers would report multiple forms of validity that have been tested in the
past; however, if every study reported just one form of validity for their measures, this would
greatly improve psychometric reporting practices. Most commonly used measures have
published validation studies; researchers are doing a disservice to the field of psychological
research if they fail to report the validity evidence that has already been generated for their
measures.
Calculate Current Psychometrics
A commonly overlooked limitation to reliability and validity evidence generated in
previous studies is its generalizability to samples, unlike the original sample. As reliability and
validity statistics are calculated from a finite sample, the only way for researchers to know
whether the reliability and validity of the measure apply to their sample is to attempt to replicate
all possible reliability and validity statistics with their own data. Although over half of the
measures published in our sampled studies from 2018 reported ICR calculated from the given
study’s data, this still means that almost half of the measures in our sample did not report an ICR
statistic generated from the current data. Calculating ICR does not require any additional data
collection, nor does it require complex statistical analyses; therefore, all researchers should be
expected to report an ICR statistic calculated from the current data. Similarly, studies employing
measures across multiple time points should be expected to calculate test-retest reliability for
their current data, and studies with measures that require an independent coder should have a
second coder for at least a portion of the data in order to calculate interrater reliability for the
study’s data. Such calculations are a type of integrity check: a way for researchers to determine
whether their measures are behaving consistently throughout their study.
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We propose that researchers also calculate all possible validity statistics from the data
they collect. Most studies we coded included at least two measures of a construct, which gives
researchers enough information to calculate convergent validity for their study. Similarly, we
encourage researchers to report any other forms of validity evidence for which they have
collected data. The types of validity evidence researchers are most likely to be able to calculate
from their studies with minimal changes to study design include construct and discriminant
validity evidence.
Clarify Writing
We propose that researchers should clarify their writing, making primary outcomes and
primary measures more explicit. Only two-thirds of articles published in 2018 clearly stated
primary outcomes and/or measures, despite the 2010 Consort Statement checklist (Schulz et al.,
2010) mandating much more rigorous reporting of primary outcome measures (p. 699) than the
current study’s coding manual of primary outcome measures. Simply adding a sentence that
clearly designates which outcomes researchers consider to be of primary interest in answering
their main research question eliminates confusion about the main focus of the study. Identifying
primary outcomes combined with pre-registration of hypotheses and analyses will help improve
the transparency of clinical trials.
Similarly, by explicitly designating which measures are considered primary measures,
researchers will eliminate confusion about which measures are directly measuring primary
outcomes. Such a clear designation of primary and secondary outcomes and measures may also
aid researchers in using fewer measures. On average, our sampled studies reported 7.5 measures
per article. Type I error rate often increases as more measures are utilized. Therefore, we propose
that researchers use no more than two to three measures to address each of the primary outcomes

RELIABILITY AND VALIDITY REPORTING IN JCCP

26

and that researchers minimize the number of secondary outcomes they include in their studies. In
addition, we propose that all measures included in the study clearly relate to one primary or
secondary outcome, as required by step 6a of the 2010 CONSORT Statement checklist (Schulz
et al., 2010, p. 699).
We also encourage researchers to explicitly report secondary outcomes and measures to
increase the clarity of their writing and research design. Similar simple changes, such as
explicitly stating the type of measure (e.g., self-report, parent report, structured interview; almost
one-third of articles did not clearly state this) and whether measures were created or altered by
the author for use in the current study, would greatly increase the transparency of researcher
practices and clarify their writing.
Report Specifics of Psychometric Evidence
Last, when reporting reliability and validity statistics, we encourage researchers to
include the statistics whenever possible. Many studies gave qualitative statements about the
reliability and validity evidence for a study (e.g., “[Measure X] has demonstrated acceptable
internal consistency reliability”); while such a statement is useful in helping others interpret
reliability and validity statistics, it should not replace the reporting of the actual statistic. In cases
where multiple studies generate a range of reliability or validity statistics, we encourage
researchers to report the entire range found across studies. By including the specific statistic in
reporting psychometric evidence for measures, consumers of research will be able to get a more
precise estimate of the overall reliability and validity of a given measure. Further, reporting of
statistics assists with peer review, both pre- and post-publication.
Similarly, we encourage researchers to report specific types of reliability and validity
evidence for each of their measures. 9.8% (44) of measures reported “good psychometric
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properties”; such a vague statement does not give the reader any idea of the types of reliability
and validity evidence that have been generated for the measure. It gives the impression of
reliability and validity for the measure in such vague language as to leave everything to the
reader’s imagination. Instead, we encourage researchers to give the specific types of reliability
and validity evidence for the measure, along with the statistics, as mentioned above.
Conclusion
In conclusion, although the implementation of reporting practices such as CONSORT
(Schulz et al., 2010) have increased the frequency of reporting reliability and validity evidence,
the current reporting frequency (18.1 – 58.1% for reliability evidence and 3.5 – 12.4% for
validity evidence) is not sufficient. Without a clear picture of the reliability and validity of our
measures, we cannot get a clear picture of the accuracy of our conclusions in scientific research.
We recommend simple changes that impose a minimal burden on researchers; yet these changes,
if implemented, have great potential to move us forward in the pursuit of truth.
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